Health X Platform Ltd filed a SEBI Regulation 7(2) insider trading continual disclosure for promoter Banwari Lal Mittal's share acquisition.
Mittal purchased 5,132 equity shares via market purchase on 19–20 March 2026 for Rs. 14,44,315.44 (inclusive of taxes).
Post-acquisition, Mittal's holding rose marginally from 1,07,76,223 shares (33.8763%) to 1,07,81,355 shares (33.8924%) of total capital.